These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25408244)

  • 1. Exploring conformational search protocols for ligand-based virtual screening and 3-D QSAR modeling.
    Cappel D; Dixon SL; Sherman W; Duan J
    J Comput Aided Mol Des; 2015 Feb; 29(2):165-82. PubMed ID: 25408244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-like bioactive structures and conformational coverage with the LigPrep/ConfGen suite: comparison to programs MOE and catalyst.
    Chen IJ; Foloppe N
    J Chem Inf Model; 2010 May; 50(5):822-39. PubMed ID: 20423098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design.
    Skalic M; Sabbadin D; Sattarov B; Sciabola S; De Fabritiis G
    Mol Pharm; 2019 Oct; 16(10):4282-4291. PubMed ID: 31437001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energy-Based Pharmacophore and Three-Dimensional Quantitative Structure--Activity Relationship (3D-QSAR) Modeling Combined with Virtual Screening To Identify Novel Small-Molecule Inhibitors of Silent Mating-Type Information Regulation 2 Homologue 1 (SIRT1).
    Pulla VK; Sriram DS; Viswanadha S; Sriram D; Yogeeswari P
    J Chem Inf Model; 2016 Jan; 56(1):173-87. PubMed ID: 26636371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ConfGen: a conformational search method for efficient generation of bioactive conformers.
    Watts KS; Dalal P; Murphy RB; Sherman W; Friesner RA; Shelley JC
    J Chem Inf Model; 2010 Apr; 50(4):534-46. PubMed ID: 20373803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avalanche for shape and feature-based virtual screening with 3D alignment.
    Diller DJ; Connell ND; Welsh WJ
    J Comput Aided Mol Des; 2015 Nov; 29(11):1015-24. PubMed ID: 26458937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.
    Sakkiah S; Thangapandian S; John S; Kwon YJ; Lee KW
    Eur J Med Chem; 2010 Jun; 45(6):2132-40. PubMed ID: 20206418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design.
    Ebalunode JO; Zheng W; Tropsha A
    Methods Mol Biol; 2011; 685():111-33. PubMed ID: 20981521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D descriptors calculation and conformational search to investigate potential bioactive conformations, with application in 3D-QSAR and virtual screening in drug design.
    da Silva CHTP; Taft CA
    J Biomol Struct Dyn; 2017 Oct; 35(13):2966-2974. PubMed ID: 27739336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of conformational flexibility on three-dimensional similarity searching using correlation vectors.
    Renner S; Schwab CH; Gasteiger J; Schneider G
    J Chem Inf Model; 2006; 46(6):2324-32. PubMed ID: 17125176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-Pharmacophore Modeling of Caspase-3 Inhibitors using Crystal, Dock and Flexible Conformation Schemes.
    Kumar SP; Jha PC
    Comb Chem High Throughput Screen; 2018; 21(1):26-40. PubMed ID: 29295689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis and optimization of structure-based virtual screening protocols (1): exploration of ligand conformational sampling techniques.
    Good AC; Cheney DL
    J Mol Graph Model; 2003 Sep; 22(1):23-30. PubMed ID: 12798388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational sampling of bioactive molecules: a comparative study.
    Agrafiotis DK; Gibbs AC; Zhu F; Izrailev S; Martin E
    J Chem Inf Model; 2007; 47(3):1067-86. PubMed ID: 17411028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents.
    Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T
    Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational sampling of druglike molecules with MOE and catalyst: implications for pharmacophore modeling and virtual screening.
    Chen IJ; Foloppe N
    J Chem Inf Model; 2008 Sep; 48(9):1773-91. PubMed ID: 18763758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore-based virtual screening.
    Horvath D
    Methods Mol Biol; 2011; 672():261-98. PubMed ID: 20838973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid shape-based ligand alignment and virtual screening method based on atom/feature-pair similarities and volume overlap scoring.
    Sastry GM; Dixon SL; Sherman W
    J Chem Inf Model; 2011 Oct; 51(10):2455-66. PubMed ID: 21870862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SwissSimilarity 2021 Web Tool: Novel Chemical Libraries and Additional Methods for an Enhanced Ligand-Based Virtual Screening Experience.
    Bragina ME; Daina A; Perez MAS; Michielin O; Zoete V
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.